Matrix metalloproteinase (MMP)-7 in salivary gland cancer

References

• Shah JP, Patel SG. Head and neck surgery and oncology. 3rd. Edinburgh: Mosby, 2003.
   Google Scholar
• Östman J, Anneroth G, Gustafsson H, Tavelin B. Malignant salivary gland tumours in Sweden 1960–1989--an epidemiological study. Oral Oncol 1997;33:169–76.
   PubMed Web of Science ®Google Scholar
• Finnish Cancer Registry. October 10th 2008. Available from: URL:http://www.cancerregistry.fi/eng/.
   Google Scholar
• Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Mäkitie A, . Salivary gland cancer in Finland 1991–96: An evaluation of 237 cases. Acta Otolaryngol 2005;125:207–14.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang HL, Shao XJ, Jiang YG, Zhao XG, Gao X, . Gene expression profile of salivary adenoid cystic carcinoma associated with perineural invasion. Tohoku J Exp Med 2007;212:319–34.
   PubMedGoogle Scholar
• De S, Fenton JE, Jones AS. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease. J Laryngol Otol 2005;119:436–42.
   PubMed Web of Science ®Google Scholar
• Ala-aho R, Kähäri VM. Collagenases in cancer. Biochimie 2005;87:273–86.
   PubMed Web of Science ®Google Scholar
• Vihinen P, Ala-aho R, Kähäri VM. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 2005;5:203–20.
   PubMed Web of Science ®Google Scholar
• Saarialho-Kere UK, Crouch EC, Parks WC. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 1995;105:190–6.
   PubMed Web of Science ®Google Scholar
• Johansson N, Kähäri VM. Matrix metalloproteinases in squamous cell carcinoma. Histol Histopathol 2000;15:225–37.
   PubMedGoogle Scholar
• Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, . Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286(5437):113–7.
   PubMedGoogle Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003;92:827–39.
   PubMed Web of Science ®Google Scholar
• Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci US 2000;97:2202–7.
   PubMed Web of Science ®Google Scholar
• Luukkaa H, Klemi P, Hirsimaki P, Vahlberg T, Kivisaari A, Kähäri VM, . Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol 2008;128:482–90.
   PubMed Web of Science ®Google Scholar
• Luukkaa H, Klemi P, Leivo I, Vahlberg T, Grenman R. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: An evaluation of 212 cases. Acta Oncol 2006;45:669–75.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Itoh F, Iku S, Adachi Y, Fukushima H, Sasaki S, . Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 2001;19:1118–27.
   PubMedGoogle Scholar
• Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000;6:1169–74.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Itoh F, Adachi Y, Fukushima H, Itoh H, Sasaki S, . Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Jpn J Clin Oncol 1999;29:58–62.
   PubMedGoogle Scholar
• Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998;79:187–94.
   PubMedGoogle Scholar
• Ito Y, Yoshida H, Kakudo K, Nakamura Y, Kuma K, Miyauchi A. Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma. Pathology 2006;38:421–5.
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007;7:800–8.
   PubMed Web of Science ®Google Scholar
• Kivisaari AK, Kallajoki M, Mirtti T, McGrath JA, Bauer JW, Weber F, . Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol 2008;158:778–85.
   PubMedGoogle Scholar
• Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Res 2007;67:6760–7.
   PubMedGoogle Scholar
• Martin MD, Matrisian LM. The other side of MMPs: Protective roles in tumor progression. Cancer Metastasis Rev 2007;26:717–24.
   PubMed Web of Science ®Google Scholar
• Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001;3:459–68.
   PubMedGoogle Scholar
• Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002;408:155–61.
   PubMed Web of Science ®Google Scholar